Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This study is to investigate how well Androgel, when tested against placebo gel, helps to
control blood sugar levels in males with type 2 diabetes who have low testosterone (the main
male hormone) blood levels and are taking oral diabetic medicines alone or in combination
with insulin.